Qin Xiao - China Reform S Board

000503 Stock   12.60  0.49  3.74%   

Executive

Qin Xiao is S Board of China Reform Health
Age 47
Address No. 18 Xilijia, Beijing, China, 100028
Phone86 10 5782 5333
Webhttps://www.crhms.cn

China Reform Management Efficiency

The company has return on total asset (ROA) of (0.0499) % which means that it has lost $0.0499 on every $100 spent on assets. This is way below average. China Reform's management efficiency ratios could be used to measure how well China Reform manages its routine affairs as well as how well it operates its assets and liabilities. At present, China Reform's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 475.4 M, whereas Total Assets are forecasted to decline to about 1.4 B.

Similar Executives

Showing other executives

EXECUTIVE Age

Feng CaiHunan Nanling Industrial
53
Yuzhen HuLoctek Ergonomic Technology
39
An DengHunan Nanling Industrial
58
Kai GuoShanghai Zhangjiang Hi Tech
44
Mi BaiLoctek Ergonomic Technology
N/A
Xiu SunInner Mongolia Furui
53
Chi WongHunan Nanling Industrial
52
Gang LiuHunan Nanling Industrial
44
Hai ZhouShandong Ruifeng Chemical
48
Zhai YongjunMing Yang Smart
46
Gang ZhengShanghai Zhangjiang Hi Tech
50
Yueling XuShandong Ruifeng Chemical
52
Chaofeng GuLoctek Ergonomic Technology
46
Jun HuangShanghai Zhangjiang Hi Tech
50
Bingguo BaoJiangsu Seagull Cooling
43
Haiguang SunLoctek Ergonomic Technology
48
Jian ChenJiangsu Seagull Cooling
51
Jian ZhangHunan Nanling Industrial
52
Yi JiangLoctek Ergonomic Technology
50
Zhihui MeiLoctek Ergonomic Technology
46
Ying LuShanghai Zhangjiang Hi Tech
51
China Reform Health (000503) is traded on Shenzhen Stock Exchange in China and employs 1,420 people. China Reform is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

China Reform Health Leadership Team

Elected by the shareholders, the China Reform's board of directors comprises two types of representatives: China Reform inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Reform's management team and ensure that shareholders' interests are well served. China Reform's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Reform's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zhongsheng Wang, General Officer
Yonghua Li, NonIndependent Mang
Qin Xiao, S Board
Yingjie Liu, Deputy Director
Hongquan Yuan, General Manager
Liqun Sun, Deputy Manager
Wenchang Wang, Chief Accountant
Dicao Sun, Deputy Director
Xuetang Huang, Financial Mang
Wei Han, President
Xinxing Liu, Board Secretary

China Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Reform a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in China Stock

China Reform financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Reform security.